Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis

BACKGROUND: The sparsity of head-to-head trials for medications used as in atopic dermatitis (AD) treatment makes therapy options difficult. OBJECTIVE: To better compare the efficacy and safety of abrocitinib and upadacitinib with dupilumab in patients with moderate-to-severe AD. METHODS: We systema...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qin, Zhao, Yanxia, Zhang, Junling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272339/
https://www.ncbi.nlm.nih.gov/pubmed/37332971
http://dx.doi.org/10.1016/j.heliyon.2023.e16704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272339/
https://www.ncbi.nlm.nih.gov/pubmed/37332971
http://dx.doi.org/10.1016/j.heliyon.2023.e16704

Ejemplares similares